1. Karimi A, Haerizadeh M, Soleymani F, Taheri F. Evaluation of medicine prescription pattern using World Health Organization prescribing indicators in Iran: A cross-sectional study. J Res Pharm Pract. 2014 Apr;3(2):39-45.
2. Emami AH, Mohammadi A, Mojtahedzadeh R, Dehpour M. Effect of an educational pamphlet on general practitioners' prescribing skill: a randomized controlled trial. Hakim. 2011; 14 (2):66-72. Persian.
3. Thamlikitkul V, Danchaivijitr S, Kongpattanakul S, Ckokloikaew S. Impact of an educational program on antibiotic use in a tertiary care hospital in a developing country. J Clin Epidemiol. 1998 Sep;51(9):773-8.
4. Asriran-Website. Iran, the second drug consumer in the world Iran. [cited 2014 Aug 3]. Available from:http://www.asriran.com/fa/news/348751.
5. Deputy Minister of Health. Prescription and distribution of drugs in Iran/injectebale drugs in more than 50%: Mehrnews [cited 2014 Aug 27]. Available from: http://www.mehrnews.com/news/2358715.
6. Khan FA, Singh VK, Sharma S, Singh P. A prospective study on the antimicrobial usage in the medicine department of a tertiary care teaching hospital. J Clin Diagn Res. 2013 Jul;7(7):1343-6.
7. Camins BC, King MD, Wells JB, Googe HL, Patel M, Kourbatova EV, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol. 2009 Oct;30(10):931-8.
8. Food and Drug Administration. Ceftriaxone and
its lethal adverse effects. [cited 19 Jun 2010]. Available from: http://vfd.kmu.ac.ir/Images/UserUpload/Document/
VFD/daru/FFF.pdf
9. Ministry of Health and Medical Education, Food and Drug Administration Drugs Statistics of Iran. [cited 2014 Nov 11]. Available from:http://fdo.behdasht.gov.ir/index.aspx?fkeyid=&siteid=114&pageid=52936&newsview=110326.
10. Food and Drug Administration. Attention about serious and lethal adverse effects of Ceftriaxone: [cited 2008 May 21]. Available from: http://fdo.tums.ac.ir/uploads/adr/77.pdf.
11. Food and Drug Administration. Re-Attention about serious and lethal adverse effects of Ceftriaxone® usage: [cited 2008 May 21]. Available from: http://fdo.tums.ac.ir/uploads/adr/87.pdf
12. Soleymani F, Valadkhani M, Dinarvand R. Challenges and achievements of promoting rational use of drugs in Iran. Iranian Journal of Public Health. 2009;38:166-8.
13. Shohrati M, Hosseini SM, Rahimian S, Parandeh A. Assessment of reasonable use of ceftriaxone in internal and surgical wards. Kowsar Medical Journal. 2010;15(3):171-6.
14. Khoshdel A, Panahandeh G. The pattern of antimicrobial utilization in patients of pediatric wards in Hajar hospital, Shahrekord, Iran in 2009-2010. J Shahrekord Univ Med Sci. 2012; 14 (5):54-62. Persian.
15. Abbasinazari M, Mohammad Alizadeh A, Jamshidi Y. Prescription of ceftriaxone before and after implementation of physician’s guidelines in a teaching hospital: a brief report. Tehran Univ Med J. 2014; 72 (3) :194-8. Persian.
16. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ. 1995 Nov 15;153(10):1423-31.
17. van der Veer SN, de Keizer NF, Ravelli AC, Tenkink S, Jager KJ. Improving quality of care. A systematic review on how medical registries provide information feedback to health care providers. Int J Med Inform. 2010 May;79(5):305-23.
18. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database of Systematic Reviews. 2012; 6.
19. Khaksari M, AhmadiKohnali J, Sepehri G, Shafiee K, Sadeghi S. Analysis of the prescription of physicians in Rafsanjan, 1993 and 1998. J Rafsanjan Univ Med Sci. 2002;1(3):163-9. Persian.
20. Cheraghali AM, Nikfar S, Behmanesh Y, Rahimi V, Habibipour F, Tirdad R, et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. East Mediterr Health J. 2004 May;10(3):406-15.
21. Sepehri GR, Meimandi MS. The quality of prescribing in general practice in Kerman, Iran. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2005;18(4-5):353-60.
)